Public Health Agency of Canada
U.S. Centers for Disease Control and Prevention
Clostridioides difficile, Clostridium difficile, C. diff
C. difficile is a bacterium that can cause mild to severe diarrhea and inflammation of the colon and can be life threatening. It is the most frequent cause of infectious diarrhea in hospitals and long-term care facilities in Canada. Most cases occur in patients who are taking certain antibiotics in high doses and over a prolonged period of time. Additional risk factors for Clostridium difficile infection include immunosuppressive therapy post-transplant, proton pump inhibitors, bowel disease and bowel surgery, and chemotherapy.
More information about C. difficile
Public Health Agency of Canada
U.S. Centers for Disease Control and Prevention
Individual cases not reportable to the Health Unit.
See the Infectious Disease Protocol, Appendix 1, for notification thresholds in hospital settings.
Should one go to childcare, school, or work if they have C. difficile?
Schools and childcare centres should exclude children:
It is not necessary to have a negative C. difficile stool test to return to school or childcare.
Note: Exclusion guidelines may differ for healthcare workers and food handlers. Follow the direction of your healthcare provider, or occupational health at your workplace.
Infection prevention and control
In addition to routine practices, clients/patients/residents suspected or confirmed to have C. difficile infection in healthcare settings should be placed on contact precautions (including single room with dedicated toileting facilities and use of personal protective equipment [gown and gloves] while in the room) and all horizontal and frequently touched surfaces in the room of the client/patient/resident should be cleaned at least twice daily, and when soiled, with a sporicidal agent. See Provincial Infectious Disease Advisory Committee: Annex C - Testing, Surveillance, and Management of Clostridium difficile in all Healthcare Settings for additional IPAC information.
Additional resources for Infection Prevention and Control:
C. difficile testing is indicated for individuals with unexplained diarrhea (e.g., ≥ three unformed feces per day without underlying diarrheal condition such as laxative use) and with risk factors for C. difficile disease (e.g., systemic antibiotic therapy, hospitalization, advanced age, impaired immunity, gastrointestinal surgery). See Public Health Ontario: Clostridioides difficile – Antigen, PCR, Susceptibility, and Typing for additional information, including acceptance/rejection criteria for specimens.
C. difficile testing is not indicated for children under the age of one year, as a test of cure, or for testing of formed stools.
Refer to the Association of Medical Microbiology and Infectious Disease Canada treatment practice guidelines for Clostridium difficile infection for recommendations on the management of initial and recurrent episodes of Clostridium difficile infection (CDI).
The Canadian Paediatric Society: Clostridium difficile in paediatric populations document summarizes information relating to the role of C. difficile in childhood diarrhea and provides recommendations for diagnosis, prevention, and treatment targeted at clinicians caring for infants and children in the community and institutional settings.
Contact our Communicable Disease Control (CDC) program at 705-474-1400 or toll free at 1-800-563-2808, ext. 5229, or by email to cdc@healthunit.ca for more information.
Last updated: Nov. 2025, by CDC